Vir Biotechnology OverviewVir Biotechnology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for VIR.
Quarterly EBIT
-$132.29M
↑ 5.21% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$467.21M
↑ 26.28% YoY
Trailing 12 months ending Mar 31, 2026
Vir Biotechnology OverviewEBIT (Earnings Before Interest and Taxes) analysis for VIR.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026